Skip to main content

Advertisement

SpringerLink
Log in

Progression of Hypermethylation of the p16 INK4A Gene from Normal Liver to Nontumorous Liver and Hepatocellular Carcinoma: An Evaluation Using Quantitative PCR Analysis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of this study was to determine to what extent hypermethylation of the p16 INK4A (p16) gene promoter is increased in nontumorous liver tissues compared with in normal liver, using two quantitative methylation-specific polymerase chain reaction (MS-PCR) methods and a bisulfite sequencing method. Methylation of the p16 gene was detected more frequently in nontumorous liver than in normal liver using the TaqMan PCR method. Methylation indices also were significantly higher in nontumorous than in normal liver. However, the bisulfite sequencing method did not detect significantly more methylation of the p16 gene in nontumorous than normal liver, nor was there a significant difference in the level of p16 mRNA. There may be a greater proportion of cells which contain methylated p16 in nontumorous than in normal liver. However, the difference was so small that the functional relevance to hepatocarcinogenesis remains elusive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15:948–963.

    Article  PubMed  CAS  Google Scholar 

  2. Shiratori Y, Yoshida H, Omata M. Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J Gastroenterol. 2001;36:73–78.

    Article  PubMed  CAS  Google Scholar 

  3. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 2002;21:2593–2604.

    Article  PubMed  CAS  Google Scholar 

  4. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687.

    Article  PubMed  CAS  Google Scholar 

  5. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196.

    Article  PubMed  CAS  Google Scholar 

  6. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428.

    Article  PubMed  CAS  Google Scholar 

  7. Bird A. The essentials of DNA methylation. Cell. 1992;70:5–8.

    Article  PubMed  CAS  Google Scholar 

  8. Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA. 1998;95:11891–11896.

    Article  PubMed  CAS  Google Scholar 

  9. Hsieh CJ, Klump B, Holzmann K, Brochard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998;58:3942–3945.

    PubMed  CAS  Google Scholar 

  10. Klump B, Hsieh CJ, Holzmann K, Gregor M, Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett’s esophagus. Gastroenterology. 1998;115:1381–1386.

    Article  PubMed  CAS  Google Scholar 

  11. Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 1998;58:4740–4744.

    PubMed  CAS  Google Scholar 

  12. Lee JH, Park SJ, Abraham SC, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene. 2004;23:4646–4654.

    Article  PubMed  CAS  Google Scholar 

  13. Kaneto H, Sasaki S, Yamamoto H, et al. Detection of hypermethylation of the p16 INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut. 2001;48:372–377.

    Article  PubMed  CAS  Google Scholar 

  14. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol. 2003;163:1371–1378.

    PubMed  CAS  Google Scholar 

  15. Di Gioia S, Bianchi P, Destro A, et al. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer. 2006;6:89–100.

    Article  PubMed  CAS  Google Scholar 

  16. Lo YM, Wong IH, Zhang J, Tein MS, Ng MH, Hjelm NM. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res. 1999;59:3899–3903.

    PubMed  CAS  Google Scholar 

  17. Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 2004;64:5511–5517.

    Article  PubMed  CAS  Google Scholar 

  18. Lehmann U, Berg-Ribbe I, Wingen LU, et al. Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res. 2005;11:3654–3660.

    Article  PubMed  CAS  Google Scholar 

  19. Harden SV, Tokumaru Y, Westra WH, et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res. 2003;9:1370–1375.

    PubMed  CAS  Google Scholar 

  20. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753–756.

    Article  PubMed  CAS  Google Scholar 

  21. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704–707.

    Article  PubMed  CAS  Google Scholar 

  22. Baek MJ, Piao Z, Kim NG, et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer. 2000;89:60–68.

    Article  CAS  Google Scholar 

  23. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. p16 INK4A is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology. 1999;116:394–400.

    Article  PubMed  CAS  Google Scholar 

  24. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology. 2000;32:970–979.

    Article  PubMed  CAS  Google Scholar 

  25. Roncalli M, Bianchi P, Bruni B, et al. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology. 2002;36:427–432.

    Article  PubMed  CAS  Google Scholar 

  26. Li X, Hui AM, Sun L, et al. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res. 2004;10:7484–7489.

    Article  PubMed  CAS  Google Scholar 

  27. Qin Y, Liu JY, Li B, Sun ZL, Sun ZF. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis. World J Gastroenterol. 2004;10:1276–1280.

    PubMed  CAS  Google Scholar 

  28. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ. Classification of chronic hepatitis: diagnosis, grading, and staging. Hepatology. 1994;19:1513–1520.

    Article  PubMed  CAS  Google Scholar 

  29. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821–9826.

    Article  PubMed  CAS  Google Scholar 

  30. Kim BN, Yamamoto H, Ikeda K, et al. Methylation and expression of p16INK4A tumor suppressor gene in primary colorectal cancer tissues. Int J Oncol. 2005;26:1217–1226.

    PubMed  CAS  Google Scholar 

  31. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994;22:2990–2997.

    Article  PubMed  CAS  Google Scholar 

  32. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol. 2000;249:101–118.

    PubMed  CAS  Google Scholar 

  33. Waki T, Tamura G, Sato M, Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene. 2003;22:4128–4133.

    Article  PubMed  CAS  Google Scholar 

  34. Narimatsu T, Tamori A, Koh N, et al. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology. 2004;47:26–31.

    Article  PubMed  CAS  Google Scholar 

  35. Muhlisch J, Bajanowski T, Rickert CH, et al. Frequent but borderline methylation of p16 INK4A and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses. J Neurooncol. 2007;83:17–29. (online first).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences of Niigata University, 1-754, Asahimachi-Dori, Niigata-city, 951-8122, Japan

    So Kurita, Shogo Ohkoshi, Masahiko Yano, Kazuhide Yamazaki, Kenta Suzuki, Yo-hei Aoki, Yasunobu Matsuda & Yutaka Aoyagi

  2. First Department of Surgery, Graduate School of Medical and Dental Sciences of Niigata University, 1-754, Asahimachi-Dori, Niigata-city, 951-8122, Japan

    Toshifumi Wakai & Yoshio Shirai

  3. Division of Gastroenterology and Hepatology, Juntendo University School of Medicine and Juntendo University Hospital of Shizuoka, Shizuoka, Japan

    Takafumi Ichida

Authors
  1. So Kurita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shogo Ohkoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahiko Yano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuhide Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenta Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yo-hei Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasunobu Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Toshifumi Wakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoshio Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takafumi Ichida
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yutaka Aoyagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shogo Ohkoshi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurita, S., Ohkoshi, S., Yano, M. et al. Progression of Hypermethylation of the p16 INK4A Gene from Normal Liver to Nontumorous Liver and Hepatocellular Carcinoma: An Evaluation Using Quantitative PCR Analysis. Dig Dis Sci 54, 80–88 (2009). https://doi.org/10.1007/s10620-008-0611-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0611-5

Keywords

Search

Navigation